We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
87 hedge funds and large institutions have $260M invested in Larimar Therapeutics in 2018 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
298% more call options, than puts
Call options by funds: $526K | Put options by funds: $132K
260% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 10
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
128% more capital invested
Capital invested by funds: $114M → $260M (+$146M)
79% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 14
43% more funds holding
Funds holding: 61 → 87 (+26)
3.02% more ownership
Funds ownership: 4.63% → 7.65% (+3%)
Holders
87
Holders Change
+26
Holders Change %
+42.62%
% of All Funds
1.99%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
36
Increased
25
Reduced
14
Closed
10
Calls
$526K
Puts
$132K
Net Calls
+$394K
Net Calls Change
+$286K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$24.8M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.97M |
| 3 |
BlackRock
New York
|
+$7.53M |
| 4 |
AC
Armistice Capital
New York
|
+$4.25M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.47M |
Top Sellers
| 1 |
NC
Nexthera Capital
New York
|
-$2.99M |
| 2 |
Man Group
London,
United Kingdom
|
-$1.02M |
| 3 |
Goldman Sachs
New York
|
-$725K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$724K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$512K |
